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Abstract
Plastic bronchitis is a rare life-threatening complication of the Fontan operation. Transcatheter Fontan
fenestration can ameliorate symptoms by decompressing elevated venous pressures. Transcatheter creation
of a fenestration can be technically challenging in cases with complex venous anatomy. We report a case of
a 5-year-old boy with heterotaxy, dextrocardia with unbalanced atrioventricular canal (AVC), atrial and
visceral situs inversus, left-sided superior vena cava (SVC), and left-sided interrupted inferior vena cava
(IVC) with azygos continuation. With few modifications to the equipment, a successful Fontan fenestration
with stent implantation was performed via transjugular approach. At 2-year follow-up, his symptoms of
plastic bronchitis improved significantly.
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INTRODUCTION
The Fontan procedure is the conventional terminal palliative procedure in children with single ventricle
physiology. Surgical fenestration of the Fontan decreases immediate postoperative morbidity, despite no
proven long-term benefits.[1] A primary indication for fenestration closure is to reduce the future risk of
paradoxical emboli. Fenestration closure, however, may increase the risk of plastic bronchitis, protein-losing
enteropathy, and liver cirrhosis.[2] Surgical versus transcatheter fenestration creation, or dilation of an
existing fenestration can improve symptoms that are refractory to medical therapy.[3] Transcatheter creation
of a fenestration can be technically challenging in cases with complex venous anatomy. We report a case of
a 5-year-old boy with single ventricle physiology and complex venous anatomy who developed plastic
bronchitis shortly after device closure of the Fontan fenestration. A fenestration was successfully recreated
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along with stent implantation across the Fontan baffle via transjugular approach.
CASE REPORT
A 5-year-old male with a history of complex congenital heart disease that included heterotaxy, dextrocardia
with atrial and visceral situs inversus, unbalanced atrioventricular canal (AVC) with mildly hypoplastic left
ventricle, ventriculoarterial concordance with aortic atresia and arch hypoplasia, left-sided superior vena
cava (SVC), and interrupted left-sided IVC with azygos continuation [Figure 1] presented to our institution
with hypoxia, persistent cough, and respiratory distress. His prior palliative procedures included
Norwood/Sano procedure as an infant followed by a Kawashima repair at 6 months of age, with subsequent
lateral tunnel fenestrated Fontan completion using Gore-Tex material at 2.5 years of age. Chylous effusions
complicated his postoperative course and he subsequently had a right pulmonary artery stent placed. At 4.5
years of age, he underwent cardiac catheterization and fenestration closure with a 4-mm Amplatzer septal
occluder (ASO) (St. Jude Medical, St Paul, MN) and occlusion of an aortopulmonary collateral using an
Amplatzer vascular plug II.
Shortly after the fenestration closure, the patient began having respiratory symptoms consistent with plastic
bronchitis but the family had relocated and had no cardiology follow-up for several months. Six months
after the closure, he presented to our institution with plastic bronchitis, on medical therapy including
steroids, beta-agonists, and chest physiotherapy. In the interim, the patient had been hospitalized twice with
hypoxia, respiratory distress, persistent cough, and intermittent facial edema. Chest X-ray showed
prominent perihilar markings, bilateral small pleural effusions, and mild pulmonary edema. His initial
echocardiogram at the time of presentation demonstrated mildly diminished ventricular function with an
ejection fraction (EF) of 53%, mild AV valve regurgitation, and a widely patent lateral caval Fontan
connection and superior cavopulmonary connection. The ASO device appeared to be in good position with
no residual shunting. The device had been in place for too long to consider device retrieval. Therefore, he
was referred for cardiac catheterization to create a Fontan fenestration.
Cardiac catheterization was performed under general anesthesia. The interrupted IVC with azygos
continuation left transhepatic and transjugular access as two primary considerations for vascular access.
Transhepatic approach was eliminated in this case because of a right dominant hepatic venous system
leaving transjugular approach as the only available approach.
Baseline mean Fontan pressure and transpulmonary gradient were 17 mmHg and 10 mmHg, respectively.
The transpulmonary gradient was measured using mean Fontan pressure and pulmonary capillary wedge
pressure (17-7 = 10 mmHg). Pulmonary vascular resistance was elevated at 4.86 Wood units*m . Systemic
oxygen saturation was 79%. Hemodynamic measurements and Fontan angiography demonstrated stable
fenestration device position without any residual shunting [Figure 2]. No additional baffle leaks or
venovenous collaterals were noted. The previously placed Amplatzer device served as the chosen landmark.
Using transesophageal echocardiography (TEE) and fluoroscopic guidance, we identified the location just
inferior to the device. This location was chosen based on the available atrial space identified by TEE relative
to the position of the device. Fontan baffle puncture was successful using a pediatric transseptal needle, but
we could not advance the 7F transseptal sheath across it. The sheath then was exchanged with an adult
transseptal sheath and an 18-gauge adult transseptal needle (Cook Medical, Bloomington, IN) was used to
cross the baffle [Figure 3]. The transseptal needle was minimally modified by slightly increasing the
curvature of the distal end of the needle to account for the angle of approach from the left internal jugular
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vein. Care was taken to not increase the needle curvature to the extent of losing the ability to apply
sufficient force against the baffle. The selected baffle site allowed us to apply sufficient force to cross the
baffle with sufficient space to not injure the posterior wall of the right atrium once crossed. The dilator
crossed, but the sheath would not cross the newly created fenestration. Therefore, the fenestration was
further dilated using a Sterling 4 mm × 2 cm balloon (Boston Scientific, Marlborough, MA) followed by
Dorado 7 mm × 4 cm balloon (BARD Peripheral Vascular Inc., Tempe, AZ). A Palmaz Genesis Blue 19
mm × 9 mm premounted stent was subsequently advanced across the Fontan baffle. Under TEE and
fluoroscopic guidance, the stent was successfully deployed across the baffle. A residual waist was left
intentionally in the stent, leaving a “dumbbell” shape to prevent stent dislodgement [Figure 4].
Postprocedure TEE and angiography confirmed stable stent position with right to left shunting across the
stent [Figure 5]. The poststent mean Fontan pressure and transpulmonary gradient were 18 mmHg and 11
mmHg, respectively. There was no immediate improvement in the transpulmonary gradient and oxygen
saturation. The patient had recovered well from the procedure and was discharged the next day.
At 6-month follow-up, the severity and frequency of his pulmonary symptoms had improved without
additional medical therapy. His oxygen saturation was 83% on room air. Follow-up echocardiography
showed stable stent position with right to left shunting and a mean gradient of 5 mmHg. A follow-up
catheterization performed 2 years later demonstrated a baseline saturation of 83%. The following
hemodynamic data are included: A mean Fontan pressure of 7-8 mmHg, transpulmonary gradient of 5-6
mmHg, ventricular end diastolic pressure of 2 mmHg, and normal pulmonary vascular resistance of 1.99
Wood units*m .
DISCUSSION
Goff et al. demonstrated that Fontan fenestration closure in suitable patients did not increase the risk of
death in the first 5-10 years. Few patients had the following features of decompensation: Developing protein
losing enteropathy, plastic bronchitis, and ascites. Their criteria not to close the fenestration was in the
setting of a decrease in cardiac output or a rise in Fontan pressure >20 mmHg with fenestration test
occlusion.[4] Despite favorable hemodynamics at baseline and with test occlusion, this patient developed
symptoms of plastic bronchitis within weeks of fenestration closure.
Plastic bronchitis is a rare and potentially life-threatening complication after the Fontan operation in which
bronchial casts are formed in the bronchi and bronchioles leading to severe and recurring airway
obstruction.[3] The contributing factors are increased pulmonary venous pressure, increased central venous
pressure, and endobronchial lymphatic leakage.[5] Standard medical therapies include steroids,
bronchodilators, pulmonary toilet, acetylcysteine, and bronchoscopic removal of casts.[3] Fenestration
creation or enlargement is another therapeutic option in the refractory cases.[5,6] Our patient had frequent
exacerbations of plastic bronchitis despite the aggressive medical therapy. Systemic venous pressure was
elevated with a mean pressure of 17 mmHg. Upon creation of a fenestration, no immediate improvement in
transpulmonary gradient and oxygen saturation were noted likely due to underlying chronic pathological
changes in the lung secondary to plastic bronchitis. Given the known disease, we deemed it reasonable to
provide time for clinical changes to occur as a result of the intervention instead of more aggressive dilation
of the fenestration that could manifest undesirable results in the ensuing months. At 6-month follow-up, the
severity of his pulmonary symptoms and frequency of exacerbations improved significantly without any
changes in medical therapy. There have been no additional casts present with coughing. His oxygen
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saturation was improved to 83% on room air. His subsequent cardiac catheterization showed favorable
hemodynamics for Fontan physiology with low ventricular end diastolic pressure (2 mmHg), low Fontan
pressures (7-8 mmHg), and a transpulmonary gradient of 5-6 mmHg.
Kreutzer et al. reported transcatheter baffle fenestration creation and/or dilation in 14 symptomatic Fontan
patients.[7] Transcatheter fenestration creation becomes more challenging in patients with complex venous
anatomy. Kobayashi et al. reported successful extracardiac Fontan fenestration creation and stent
implantation through transhepatic approach in a 4-year-old girl with dextrocardia, interrupted IVC with
azygos continuation to a right SVC.[8] Our patient had complex venous anatomy with left-sided interrupted
IVC with azygos continuation to a left SVC, precluding femoral access. A transhepatic approach was
eliminated in our case due to a dominant right hepatic venous system, leaving transjugular approach the best
option for access. With minimal modification of equipment and carefully selecting a location to allow
adequate force to be applied while providing adequate space in the adjoining atrium, and the fenestration
was successfully created. Nevertheless, this approach is more difficult as the transseptal needle enters
parallel to the target, and while the curve of the needle is necessary to engage the baffle wall, it also
diminishes the effective force needed to cross the material. TEE guidance aided this effort by affording
visibility of surrounding structures to identify the optimal location to apply the required force.
CONCLUSION
This report highlights successful stent fenestration creation of a lateral caval Fontan in a patient with
complex venous anatomy suffering from plastic bronchitis after prior device closure of the surgical
fenestration. With minor modifications to the equipment, Fontan fenestration was possible despite an
uncommon and complex anatomic substrate.
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Figures and Tables
Figure 1
Anatomical sketch: Dextrocardia, situs inversus, unbalanced AV canal, AV VA concordance, s/p lateral caval Fontan
procedure. Left ventricle (LV), right ventricle (RV), right atrium (RA), left atrium (LA), right pulmonary artery (RPA), left
Creating a Fontan fenestration in a child with dextrocardia and interrupted inferior vena cava
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867808/?report=printable[7/18/2017 8:52:50 AM]
pulmonary artery (LPA), ascending aorta (ASAo), descending aorta (DSAo)
Figure 2
Fontan baffle angiography (lateral orientation 37 degree) demonstrating a widely patent Fontan baffle. The ASO device is
in place with no residual shunting. Right pulmonary artery (RPA), left pulmonary artery (LPA)
Figure 3
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Demonstrates Fontan baffle puncture inferior to ASO device using an adult transseptal needle
Figure 4
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Using TEE guidance, a 19 mm Palmaz Blue stent, premounted on a 9-mm balloon, was deployed leaving a mild residual
waist for stent stability (“dumbbell” shape)
Figure 5
Creating a Fontan fenestration in a child with dextrocardia and interrupted inferior vena cava
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867808/?report=printable[7/18/2017 8:52:50 AM]
Poststent angiography in the Fontan baffle showing stable stent position with right to left shunting
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